Increased hindrance on the chiral carbon atom of mexiletine enhances the block of rat skeletal muscle Na+ channels in a model of myotonia induced by ATX

被引:17
作者
Desaphy, JF
Camerino, DC [1 ]
Franchini, C
Lentini, G
Tortorella, V
De Luca, A
机构
[1] Univ Bari, Dept Pharmacobiol, Pharmacol Unit, Fac Pharm, I-70125 Bari, Italy
[2] Univ Bari, Fac Pharm, Dept Med Chem, I-70125 Bari, Italy
关键词
Na+ channel; rat skeletal muscle; patch clamp; mexiletine derivative; sea anemone toxin; myotonia;
D O I
10.1038/sj.bjp.0702901
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The antiarrhythmic drug mexiletine (Mex) is also used against myotonia. Searching for a more efficient drug, a new compound (Me5) was synthesized substituting the methyl group on the chiral carbon atom of Mex by an isopropyl group. Effects of Me5 on Na+ channels were compared to those of Mex in rat skeletal muscle fibres using the cell-attached patch clamp method. 2 Me5 (10 mu M) reduced the maximal sodium current (I-Na) by 29.7+/-4.4 % (n = 6) at a frequency of stimulation of 0.3 Hz and 65.7+/-4.4 % (n=6) at 1 Hz. At same concentration (10 mu M), Mex was incapable of producing any effect (n=3). Me5 also shifted the steady-state inactivation curves by -7.9+/-0.9 mV (n = 6) at 0.3 Hz and -12.2+/-1.0 mV (n = 6) at 1 Hz. 3 In the presence of sea anemone toxin II (ATX; 5 mu M), I-Na decayed more slowly and no longer to zero, providing a model of sodium channel myotonia. The effects of Me5 on peak I-Na were similar whatever ATX was present or not. Interestingly, Me5 did not modify the I-Na decay time constant nor the steady-state I-Na to peak I-Na ratio. 4 Analysis of ATX-induced late Na+ channel activity shows that Me5 did not affect mean open times and single-channel conductance, thus excluding open channel block property. 5 These results indicate that increasing hindrance on the chiral atom of Mex increases drug potency on wild-type and ATX-induced noninactivating I-Na and that Me5 might improve the prophylaxis of myotonia.
引用
收藏
页码:1165 / 1174
页数:10
相关论文
共 41 条
[1]  
CANNON SC, 1993, J PHYSIOL-LONDON, V466, P501
[2]   From mutation to myotonia in sodium channel disorders [J].
Cannon, SC .
NEUROMUSCULAR DISORDERS, 1997, 7 (04) :241-249
[3]   THEORETICAL RECONSTRUCTION OF MYOTONIA AND PARALYSIS CAUSED BY INCOMPLETE INACTIVATION OF SODIUM-CHANNELS [J].
CANNON, SC ;
BROWN, RH ;
COREY, DP .
BIOPHYSICAL JOURNAL, 1993, 65 (01) :270-288
[5]  
Colquhoun Colquhoun D. D., SINGLE CHANNEL RECOR, P191
[6]   WHY DO SOME DRUGS PREFERENTIALLY BLOCK OPEN SODIUM-CHANNELS [J].
COURTNEY, KR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1988, 20 (06) :461-464
[8]   Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide [J].
De Luca, A ;
Natuzzi, F ;
Falcone, G ;
Duranti, A ;
Lentini, G ;
Franchini, C ;
Tortorella, V ;
Camerino, DC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (06) :777-787
[9]  
DeLuca A, 1997, J PHARMACOL EXP THER, V282, P93
[10]   Effect of mexiletine on sea anemone toxin-induced non-inactivating sodium channels of rat skeletal muscle: a model of sodium channel myotonia [J].
Desaphy, JF ;
Camerino, DC ;
Tortorella, V ;
De Luca, A .
NEUROMUSCULAR DISORDERS, 1999, 9 (03) :182-189